Literature DB >> 16221810

Risk factors for pelvis fracture in older persons.

Jennifer L Kelsey1, Mila M Prill, Theresa H M Keegan, Charles P Quesenberry, Steven Sidney.   

Abstract

From 1996 to 2001, the authors undertook a case-control study of 192 pelvis fracture cases (men and women) and 2,402 controls aged > or = 45 years at five Kaiser Permanente medical centers in Northern California. Most information on potential risk factors was obtained by means of an interviewer-administered questionnaire. Number of fractures since age 45 years and a maternal history of hip fracture were associated with increased risks. Several factors thought to protect against loss of bone mass, including recent use of menopausal hormone therapy (adjusted odds ratio (OR) = 0.55, 95% confidence interval (CI): 0.33, 0.91) and high body mass index (weight (kg)/height (m)2; per 5-unit increase, adjusted OR = 0.65, 95% CI: 0.52, 0.81), were associated with decreased risks, while cigarette smoking (adjusted OR = 2.17, 95% CI: 1.34, 3.52) and hysterectomy (adjusted OR = 1.75, 95% CI: 1.15, 2.66) were associated with increased risks. Various conditions related to propensity to fall were associated with increased risks. Most indicators of frailty, including use of walking aids and needing help with or being unable to perform various activities of daily living, conferred increased risks. Thus, low bone mass, frailty, and probably a propensity to fall appear to be associated with increased risk of pelvis fracture.

Entities:  

Mesh:

Year:  2005        PMID: 16221810     DOI: 10.1093/aje/kwi295

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

Review 1.  The effects of smoking on bone metabolism.

Authors:  V Yoon; N M Maalouf; K Sakhaee
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

2.  The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid.

Authors:  S L Brennan; K L Holloway; L J Williams; M A Kotowicz; G Bucki-Smith; D J Moloney; A G Dobbins; E N Timney; J A Pasco
Journal:  Osteoporos Int       Date:  2015-01-09       Impact factor: 4.507

3.  Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

4.  A Nationwide Analysis of Pelvic Ring Fractures: Incidence and Trends in Treatment, Length of Stay, and Mortality.

Authors:  Leonard T Buller; Matthew J Best; Stephen M Quinnan
Journal:  Geriatr Orthop Surg Rehabil       Date:  2016-03

5.  Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis.

Authors:  Tesfaye Getachew Charkos; Yawen Liu; Lina Jin; Shuman Yang
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

6.  Risk of Pelvic Fracture With Radiation Therapy in Older Patients.

Authors:  Lucas K Vitzthum; Helen Park; Kaveh Zakeri; Elena S Heide; Vinit Nalawade; Arno J Mundt; Florin Vaida; James D Murphy; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-10-11       Impact factor: 7.038

7.  Survivorship and severe complications are worse for octogenarians and elderly patients with pelvis fractures as compared to adults: data from the national trauma data bank.

Authors:  Amir Matityahu; Joshua Elson; Saam Morshed; Meir Marmor
Journal:  J Osteoporos       Date:  2012-11-07

8.  Epidemiology of Pelvic Fractures in Germany: Considerably High Incidence Rates among Older People.

Authors:  Silke Andrich; Burkhard Haastert; Elke Neuhaus; Kathrin Neidert; Werner Arend; Christian Ohmann; Jürgen Grebe; Andreas Vogt; Pascal Jungbluth; Grit Rösler; Joachim Windolf; Andrea Icks
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

9.  Health care utilization and excess costs after pelvic fractures among older people in Germany.

Authors:  S Andrich; B Haastert; E Neuhaus; K Frommholz; W Arend; C Ohmann; J Grebe; A Vogt; C Brunoni; P Jungbluth; S Thelen; C-M Dintsios; J Windolf; A Icks
Journal:  Osteoporos Int       Date:  2021-04-10       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.